Show simple item record

dc.contributor.advisorOchoa Vera, Miguel Enrique
dc.contributor.advisorLubinus Badillo, Federico Guillermo
dc.contributor.authorOrtiz Cala, Oscar Leonel
dc.date.accessioned2020-06-26T20:07:18Z
dc.date.available2020-06-26T20:07:18Z
dc.date.issued2015
dc.identifier.urihttp://hdl.handle.net/20.500.12749/1863
dc.description.abstractLa esteatosis hepática o hígado graso (HG) es un depósito principalmente de triacilgliceridos, dentro del hepatocito y que usualmente excede al 5% del volumen hepático, tradicionalmente se ha considerado como una condición benigna y reversible, siendo una expresión del hígado ante un estrés metabólico de diferentes orígenes.(1) puede presentar una evolución hacia la esteatohepatitis, con el eventual desarrollo de cirrosis no alcohólica no colestásica y el riesgo de carcinoma hepatocelular.(2) Esta patología afecta alrededor del 1-51% de la población adulta, variabilidad explicada por los diversos tipos de estudios poblacionales así como por las diferentes causas que conllevan a este diagnóstico. (2) La urolitiasis es una patología prevalente con alta recurrencia, que no solo genera dolor sino también un alto costo económico importante que va desde la limitación laboral al costo terapéutico, teniendo en cuenta que los procedimiento quirúrgicos no evitan la recurrencia de la patología, en comparación con los cambios que genera modificar el estilo de vida. (3) Actualmente ha aumento la incidencia y prevalencia de urolitiasis a nivel mundial, con variaciones que oscilan entre 16.9% al 18.5% dependiendo de la población de interés, se han reportado incidencias de 1116 por 100.000 habitantes en edades promedio entre los 40-49 años y con mayor frecuencia en hombres. (4,5) ASCOFAME para 1998 publico egresos por litiasis renal que corresponde a 13 por 1000 consultas, con una mayor frecuencia en climas cálidos. (6) Por consiguiente aproximadamente el 5% de las mujeres y el 12% de los hombres desarrollaran un episodio de litiasis en algún momento de su vida, lo cual generara un gasto anual cercano a 2.1 billones de dólares. (7) Estudios observacionales han sugerido la asociación entre hígado graso y la formación de litiasis renal, especialmente en dietas con alto contenido de colesterol que ocasionan, aumento en las concentraciones de oxalato de calcio en orina con la consiguiente formación de cálculos renales.spa
dc.description.tableofcontents1. INTRODUCCION………………..6 1.1. Hígado Graso……………….....7 1.1.1. Clínica y Factores de Riesgo………………….7 1.1.2. Evaluación del hígado graso por métodos de imagen (tomografía)...9 1.1.2.1. Hallazgos tomográficos………….10 1.1.2.1.1. Forma focal………………..10 1.1.2.1.2. Forma difusa……………10 1.2. Litiasis Renal…………………….12 1.2.1. Clínica…………………..12 1.2.2. Urotomografía ( UROTC)……………..12 1.2.2.1. Signos tomográficos……………..13 1.2.2.2. Volumen o peso del cálculo………..14 1.2.2.3. Fragilidad del cálculo………….14 1.2.2.4. Composición del cálculo…………14 1.3. Asociación entre hígado graso y urolitiasis…………………..15 2. OBJETIVOS………………..18 3. MATERIALES Y METODOS………………..19 3.1. Plan de análisis………….20 3.2. Consideraciones éticas. …………….20 4. RESULTADOS…………………….23 5. DISCUSIÓN………………..31 6. CONCLUSIONES………...36 7. REFERENCIAS…...37 8. ANEXO………………………..43spa
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleCaracterísticas imagenológicas en TAC de la esteatosis hepática, urolitiasis y su relaciónspa
dc.title.translatedCT imaging characteristics of hepatic steatosis, urolithiasis and their relationshipeng
dc.degree.nameEspecialista en Radiología e Imágenes Diagnósticas
dc.coverageBucaramanga (Santander, Colombia)
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNAB
dc.rights.localAbierto (Texto Completo)spa
dc.publisher.facultyFacultad Ciencias de la Salud
dc.publisher.programEspecialización en Radiología e Imágenes Diagnósticas
dc.description.degreelevelEspecialización
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.localTesisspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.subject.keywordsHepatic steatosis
dc.subject.keywordsUrolithiasis
dc.subject.keywordsX-ray image
dc.subject.keywordsMedicine
dc.subject.keywordsRadiology
dc.subject.keywordsDiagnostic images
dc.subject.keywordsDiagnostic imaging
dc.subject.keywordsX-rays
dc.subject.keywordsInvestigations
dc.subject.keywordsAnalysis
dc.subject.keywordsCliniceng
dc.subject.keywordsRisk factorseng
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNAB
dc.identifier.reponamereponame:Repositorio Institucional UNAB
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2
dc.relation.referencesOrtiz Cala, Oscar Leonel (2015). Características imagenológicas en tac de la esteatosis hepática, urolitiasis y su relación. Bucaramanga (Colombia) : Universidad Autónoma de Bucaramanga UNAB
dc.relation.referencesBellentani S. Bedogni G, Miglioli L, Tiribelli C. The epidemiology of fatty liver. Eur J Gastroenterol Hepatol. 2004, 16: 1087-1093.
dc.relation.referencesLazo M, Clark J M. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008; 28(4): 339-350.
dc.relation.referencesStamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003; 63: 1817-1823.
dc.relation.referencesJanice Jou, M.D., Steve S. Choi, M.D., and Anna Mae Diehl, M.D. Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease Semin Liver Dis 2008; 28: 370–379.
dc.relation.referencesPaul Angulo. Nonalcoholic fatty liver disease. N Engl J Med. 2002 Vol. 346, (16):1221-31.
dc.relation.referencesSordenman T W, et al. guía práctica clínica basada en la evidencia de litiasis renal y ureteral, ISS-ASCOFAME.
dc.relation.referencesRomero V, Akpinar H, Assimos D G. kidney stones: a global picture of prevalence, incidence and associate risk factors. Rev Urol, 2010 12 (2): e86-e96
dc.relation.referencesElizabeth m. Brunt, md. Nonalcoholic steatohepatitis: Definition and pathology. Seminars in liver disease. 2001 Vol 21, (1). 3-16.
dc.relation.referencesShi Lei, Liu Zhong Wu, Li Yun, Gong Cai, Zhang Huang, Song Li Huang. Huang Cheng Yu and Li Ming. The Prevalence of Nonalcoholic Fatty Liver Disease and its Association with Lifestyle/dietary Habits among University Faculty and Staff in Chengdu. Biomed Environ Sci. 2012; 25(4): 383-391.
dc.relation.referencesNeuschwander-tetri et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 2010; 52: 913-924.
dc.relation.referencesPuneet Puri. Arun J. Sanyal. Nonalcoholic Fatty Liver Disease: Definitions, Risk Factors, and Workup. Clinical Liver Disease. 2012 Vol.1. (4): 99- 103.
dc.relation.referencesNoureddin M, Loomba R. Nonalcoholic fatty liver disease: indications for liver biopsy and noninvasive biomarkers. Clin Liver Dis 2012; 1: 104-107.
dc.relation.referencesN. Chalasani. Z. Younossi. Joel E. Lavine. A. Diehl. Et al. The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012 Vol. 55 (6):2005-2023.
dc.relation.referencesGeoffrey C. Farrell and Claire Z. Larter. Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis. Hepatology 2006; 43: S99-S112.
dc.relation.referencesM. Ekstedt. L. E. Franz´en. Et al. Long-Term Follow-up of Patients with NAFLD and Elevated Liver Enzymes. Hepatology 2006; 44: 865-873.
dc.relation.referencesN. Rafiq. C. Bai. Y. Fang. et al. Long-Term Follow-Up of Patients with Nonalcoholic Fatty Liver. Clinical Gastroenterology and Hepatology 2009;7:234–238
dc.relation.referencesM. Massaro Ceballos. C. P. Huertas. T. I. Ruiz. Espectro de tomografía computada e imágenes por resonancia magnética de la esteatosis hepática. Rev Colomb Radiol. 2013; 24(1): 3654-60.
dc.relation.referencesLimanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, SaabS, LuDS.Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologicfindings. Radiology. 2004; 230 (1):276-80.
dc.relation.referencesPark SH, Kim PN, KIM KW, Lee SW, Yoon SE; Park SW, Ha HK, Lee MG, Hwang S, Lee SG, Yu ES; Cho EY. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology. 2006: 239 (1): 105-12.
dc.relation.referencesAnneloes E. Bohte. Jochem R. van Werven. Shandra Bipat. Jaap Stoker. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol (2011) 21:87–97.
dc.relation.referencesOkka W. Hamer. Diego A. Aguirre. Giovanna Casola. Claude B. Sirlin. Imaging Features of Perivascular Fatty Infiltration of the Liver: Initial Observations. Radiology. 2005 Oct; 237 (1):159-69.
dc.relation.referencesPrasad sr, Wang H, Rosas H, Menias CO, Narra VR, Middleton WD, Heiken JP Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics. 2005 Mar-Apr; 25 (2):321-31.
dc.relation.referencesXiaozhou Ma, Nagaraj-Setty Holalkere, Avinash Kambadakone R,Mari Mino-Kenudson, Peter F. Hahn, Dushyant V. Sahani. Imaging-based Quantification of Hepatic Fat: Methods and Clinical Applications. Radiographics. 2009; 29:1253–1280.
dc.relation.referencesMaki Tobari, Etsuko Hashimoto, Satoru Yatsuji, Nobuyuki Torii and Keiko Shiratori. Imaging of Nonalcoholic Steatohepatitis: Advantages and Pitfalls of Ultrasonography and Computed Tomography. Inter Med 2009 vol. 48: 739-746.
dc.relation.referencesPhunchai Charatcharoenwitthaya. Keith D. Lindor. Role of Radiologic Modalities in the Management of Non-alcoholic Steatohepatitis. Clin Liver Dis. 2007 vol. (11): 37–54.
dc.relation.referencesLee SW, Park SH, Kim KW, Choi EK, Shin YM, Kim PN, Lee KH, Yu ES. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison ofvisual grading with liver attenuation index. Radiology. 2007 Aug; 244 (2):479-85.
dc.relation.referencesCarlos Valls. Ricardo Iannacconne. Esther Alba. Takamichi Murakami. Masatoshi Hori. Roberto Passariello. Valérie Vilgrain. Fat in the liver: diagnosis and characterization. Eur Radiol (2006) 16: 2292–2308.
dc.relation.referencesEvan s. Siegelman. Mark a. Rosen. Imaging of hepatic steatosis. Seminars in liver disease. 2001. Vol 21, (1) 71-80
dc.relation.referencesN. F. Schwenzer. F Springer. C Schraml. N Stefan. Ju¨rgen Machann. F. Schick. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. Journal of Hepatology 2009. vol. 51: 433–445.
dc.relation.referencesHoppe H, Studer R, Kessler TM, et al. Alternate or additional findings to stone disease on unenhanced computerized tomography for acute flank pain can impact management. J Urol. 2006; 175: 1725-30.
dc.relation.referencesAther MH, Faizullah K, Achakzai I, et al. Alternate and incidental diagnoses on noncontrast-enhanced spiral computed tomography for acute flank pain. Urol J. 2009; 6: 14-8.
dc.relation.referencesMoe, Orson W. Kidney stones: pathophysiology and medical management. The Lancet; Jan 28-Feb 3, 2006; 367, 9507.
dc.relation.referencesJindal G, Ramchandani P. Acute flank pain secondary to urolithiasis: radiologic evaluation and alternate diagnoses. Radiol Clin North Am. 2007; 45: 395-410.
dc.relation.referencesTamm EP, Silverman PM, Shuman WP. Evaluation of the patient with flank pain and possible ureteral calculus. Radiology .2003; 228: 319-29.
dc.relation.referencesZ Restrepo. F. Múnera. S Villa. J López. A López. Uro-TAC, más allá del cálculo. Rev. Colomb Radiol. 2011; 22:(3):3252-62.
dc.relation.referencesB H. Eisner J W. McQuaid E Hyams B R. Matlaga. Nephrolithiasis: What Surgeons Need to Know. AJR 2011; 196:1274–1278.
dc.relation.referencesTublin ME, Murphy ME, Delong DM, et al. Conspicuity of renal calculi at unenhanced CT: effects of calculus composition and size and CT technique. Radiology. 2002; 225:91-6.
dc.relation.referencesBlake SP, McNicholas MM, Raptopoulos V. Non opaque crystal deposition causing ureteric obstruction in patients with HIV undergoing indinavir therapy. AJR Am J Roentgenol. 1998; 171:717-20.
dc.relation.referencesAvinash R. Kambadakone, Brian H. Eisner, Onofrio Antonio Catalano, Dushyant V. Sahani. New and Evolving Con¬cepts in the Imaging and Management of urolithiasis: Urologists’ Perspective. Radiographics 2010; 30:603–623.
dc.relation.referencesMikako obika. Hirofumi Noguchi. Diagnosis and evaluation of nonalcoholic fatty liver disease. Experimental diabetes research Volume 2012, article id 145754, 12 pages doi:10.1155/2012/145754.
dc.relation.referencesDaniel T. Boll. Elmar M. Merkle. Diffuse Liver Disease: Strategies for Hepatic CT and MR Imaging. Radiographics 2009; 29:1591–1614
dc.relation.referencesAngelo H. Paredes. Dawn M. Torres. Stephen A. Harrison. Nonalcoholic Fatty Liver Disease. Clin Liver Dis. 2012, vol (12): 397–419.
dc.relation.referencesEge G, Akman H, Kuzucu K, Yildiz S. Acute ureterolithiasis: incidence of secondary signs on unenhanced helical CT and influence on patient management. Clin Radiol 2003; 58:990–994.
dc.relation.referencesB Türkbey, E Akpınar, Ç Özer, E Bengi V Eken, M Karçaaltıncaba, O Akhan. Multidetector CT technique and imaging findings of urinary Stone disease: an expanded review. Diagn Interv Radiol 2010; 16:134–144.
dc.relation.referencesM Lidén T Andersson M Broxvall Per Thunberg H Geijer. Urinary stone size estimation: a new segmentation algorithm-based CT method. Eur Radiol (2012) 22:731–737.
dc.relation.referencesTerri J. Vrtiska. Quantitation of stone burden: imaging advances. Urol Res (2005) 33: 398–402.
dc.relation.referencesBandi G, Meiners RJ, Pickhardt PJ, Nakada SY. Stone measurement by volumetric three-dimen¬sional computed tomography for predicting the outcome after extracorporeal shock wave litho¬tripsy. BJU Int 2009; 103 (4):524–528.
dc.relation.referencesWang LJ, Wong YC, Chuang CK, et al. Predictions of outcomes of renal stones after extracorporeal shock wave lithotripsy from stone characteristics de¬termined by unenhanced helical computed tomog¬raphy: a multivariate analysis. Eur Radiol 2005;15 (11):2238–2243
dc.relation.referencesC A Zarse, T A. Hameed, M E. Jackson, Y A. Pishchalnikov, J E. Lingeman,J A. McAteer, J C. Williams Jr. CT visible internal stone structure—but not Hounsfield unit value —of calcium oxalate monohydrate (COM) calculi predicts lithotripsy fragility in vitro. Urol Res. 2007. 35(4): 201–206.
dc.relation.referencesP M. Cheng, P Moin. M D. Dunn. W D. Boswell. V A. Duddalwar. What the Radiologist Needs to Know About Urolithiasis: Part 2—CT Findings, Reporting, and Treatment. AJR 2012; 198:W548–W554.
dc.relation.referencesP M. Cheng, P Moin. M D. Dunn. W D. Boswell. V A. Duddalwar. What the Radiologist Needs to Know About Urolithiasis: Part 1— Pathogenesis, Types, Assessment, and Variant Anatomy. AJR 2012; 198:W540–W547.
dc.relation.referencesBellin MF, Renard-Penna R, Conort P, et al. Hel-ical CT evaluation of the chemical composition of urinary tract calculi with a discriminant analy¬sis of CT-attenuation values and density. Eur Ra¬diol 2004; 14 (11):2134–2140.
dc.relation.referencesC. Westphalen, R Y. Hsia, J H. Maselli, R Wang, R Gonzales. Radiological Imaging of Patients with Suspected Urinary Tract Stones: National Trends, Diagnoses, and Predictors. Acad Emerg Med. 2011 July; 18(7): 699–707.
dc.relation.referencesA M. Potretzke. M Monga. Imaging modalities for urolithiasis: impact on management. Current Opinion in Urology 2008, 18:199–204.
dc.relation.referencesLaughlin, L. Crush, M. M. Maher, and O. J.O’Connor. Recent Developments in Computed Tomography for Urolithiasis: Diagnosis and Characterization. Advances in Urology. Volume 2012, ID 606754.
dc.relation.referencesY. NAYA, H. ITO, M. MASAI K. YAMAGUCHI. Association of dietary fatty acids with urinary oxalate excretion in calcium oxalate stone-formers in their fourth decade. BJU International (2002), 89, 842–846.
dc.relation.referencesB Baggio, A Budakovic, M A Nassuato, G Vezzoli, E Manzato, G Luisetto, M Zaninotto. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney International, Vol. 58 (2000), 1278–1284.
dc.relation.referencesBaggio, B. Budakovic, Alessandro priante, Giovanna Gambaro. Dietary fatty acid supplementation modulates the urinary excretion of calcium and oxalate in the rat. Nephron; Jul 2002; 91, 3.
dc.relation.referencesSchmiedl A, Schwille PO, Bonucci E, Erben RG, Grayczyk A, Sharma V. Nephrocalcinosis and hyperlipidemia in rats fed a cholesterol- and fat-rich diet: association with hyperoxaluria, altered kidney and bone minerals, and renal tissue phospholipid-calcium interaction. Urol Res. 2000 Dec; 28 (6):404-15.
dc.relation.referencesCraig B. Langman. The molecular basis of kidney stones. Current Opinion in Pediatrics 2004, 16:188–193.
dc.relation.referencesAndrew P. Evan. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol (2010) 25:831–841.
dc.relation.referencesGroen J. An experimental Syndrome of Fatty liver, Uric Acid Kidney Stones and Acute Pancreatic Necrosis Produced in Dogs by Exclusive Feeding of Bacon. Science. 1948. 107 (2782): 425-6.
dc.relation.referencesGrases, A Costa-Bauza R M Prieto. Renal lithiasis and nutrition. Nutrition Journal 2006, 5:23 1-7.
dc.relation.referencesKhashayar Sakhaee. Recent advances in the pathophysiology of nephrolithiasis. Kidney International (2009) 75, 585–595.
dc.relation.referencesBorghi L, Tiziana M, Prati B, Maggiore U. Dietary therapy in idiopathic nephrolithiasis. Nutrition rev. 2006; 7 (1): 301-312.
dc.relation.referencesEinollahi B, Naghii MR, Sepandi M. Association of nonalcoholic fatty liver disease (NAFLD) with urolitiasis. Endocrine regulations. 2013 Vol:47, 27-32.
dc.relation.referencesJ. Carrasco-Valiente. F.J. Anglada-Curado. P. Aguilar-Melero. R. González-Ojeda. J. Muntané-Relat. F.J. Padillo-Rui. M.J. Requena-Tapia. Estado de los marcadores de fase aguda y estrés oxidativo en los enfermos con litiasis de la vía urinaria. Actas Urol Esp. 2012; 36 (5):296---301.
dc.relation.referencesF C Miranda Torricelli. Shubha K. De. Surafel Gebreselassie. Ina Li. Carl Sarkissian. Manoj Monga. Dyslipidemia and Kidney Stone Risk. The Journal of Urology. 2014. (191) 667-672.
dc.relation.referencesJames H. Masterson. Jason R. Woo. David C. Chang. Thomas Chi. James O. L’Esperance. Marshall L. Stoller. Roger L. Sur. Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis. 2015; 43(1):49-53.
dc.relation.referencesHo Won Kang. Sung Pil Seo. Won Tae Kim. Yong-June Kim. Seok-Joong Yun, Sang-Cheol Lee. Wun-Jae Kim. Hypertriglyceridemia Is Associated With Increased Risk for Stone Recurrence in Patients With Urolithiasis. Urology. 2014 .84(4):766-71
dc.relation.referencesC Freitas Junior, E Mazzucchi, A Danilovic, Artur Henrique Brito, Miguel Srougi. Metabolic assessment of elderly men with urolitiasis. Clinics. 2012; 67 (5):457-461.
dc.relation.referencesSung Tae Cho. Seung Il Jung. Soon Chul Myung. Tae Hyoung Kim. Correlation of metabolic syndrome with urinary stone composition. International Journal of Urology (2013) 20, 208–213.
dc.relation.referencesWong YV, Cook P, Somani BK. The association of metabolic syndrome and urolithiasis. Int J Endocrinol. 2015; ID: 570674.
dc.relation.referencesLisa B. VanWagner. Hongyan Ning. Cora E. Lewis. Christina M. Shay. John Wilkins. J. Jeffrey Carr. James G. Terry. Donald M. Lloyd-Jones. David R. Jacobs Jr. Mercedes R. Carnethon. Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study. Atherosclerosis. 2014; 235: 599- 605.
dc.relation.referencesJiankang Liu. Solomon K. Musani. Aurelian Bidulescu. J. Jeffery Carr. James G. Wilson. Herman A. Taylor. Caroline S. Fox. Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: The Jackson Heart Study. Atherosclerosis. 2012; 224: 521-525.
dc.relation.referencesTakahiro Yasui.Yasunori itoh. Gao Bing. Atsushi Okada. Keiichi Tozawa. Kenjiro K.ohri. Aortic calcification in urolithiasis patients. Scandinavian Journal of Urology and Nephrology, 2007; 41: 419-421.
dc.relation.referencesR Siener, J Petzold, N Bitterlich, B Alteheld, C Metzner. Determinants of Urolithiasis in Patients With Intestinal Fat Malabsorption. Urology 2013; 81: 17-24.
dc.relation.referencesReddy SK, Zhan M, Alexander HR, El-Kamary SS. Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders. World J Gastroenterol. 2013 Dec 7; 19(45):8301-11.
dc.relation.referencesSabaté JM, Jouët P, Harnois F, Mechler C, Msika S, Grossin M, Coffin B. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg 2008; 18: 371-377.
dc.contributor.cvlachttps://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0000898465
dc.contributor.orcidhttps://orcid.org/0000-0002-4552-3388
dc.contributor.scopushttps://www.scopus.com/authid/detail.uri?authorId=36987156500
dc.contributor.researchgatehttps://www.researchgate.net/profile/Miguel_Ochoa7
dc.subject.lembEsteatosis hepáticaspa
dc.subject.lembUrolitiasisspa
dc.subject.lembImagen para rayos Xspa
dc.subject.lembMedicinaspa
dc.subject.lembRadiologíaspa
dc.subject.lembImágenes diagnósticasspa
dc.subject.lembDiagnóstico por imagenspa
dc.subject.lembRadiografíasspa
dc.subject.lembInvestigacionesspa
dc.subject.lembAnálisisspa
dc.description.abstractenglishHepatic steatosis or fatty liver (HG) is a deposit mainly of triacylglycerides, within the hepatocyte and that usually exceeds 5% of the liver volume, traditionally it has been considered as a benign and reversible condition, being an expression of the liver in the face of metabolic stress of different origins. (1) it may present an evolution towards steatohepatitis, with the eventual development of non-alcoholic non-cholestatic cirrhosis and the risk of hepatocellular carcinoma. (2) This pathology affects around 1-51% of the adult population, variability explained by the various types of population studies as well as by the different causes that lead to this diagnosis. (two) Urolithiasis is a prevalent pathology with high recurrence, which not only generates pain but also an important high economic cost that ranges from labor limitation to therapeutic cost, taking into account that surgical procedures do not prevent the recurrence of the pathology, compared to the changes generated by modifying the lifestyle. (3) Currently, the incidence and prevalence of urolithiasis has increased worldwide, with variations that range between 16.9% to 18.5% depending on the population of interest, incidences of 1116 per 100,000 inhabitants have been reported in average ages between 40-49 years and more often in men. (4,5) ASCOFAME for 1998 published discharges for kidney stones that correspond to 13 per 1000 consultations, with a higher frequency in hot climates. (6) Consequently, approximately 5% of women and 12% of men will develop an episode of lithiasis at some point in their life, which will generate an annual expense of close to 2.1 billion dollars. (7) Observational studies have suggested the association between fatty liver and the formation of kidney stones, especially in diets with a high cholesterol content that cause an increase in calcium oxalate concentrations in urine with the consequent formation of kidney stones.eng
dc.subject.proposalClínicaspa
dc.subject.proposalFactores de riesgospa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 2.5 Colombia
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 2.5 Colombia